Skip to main content
. 2017 Jul 7;15(7):e04783. doi: 10.2903/j.efsa.2017.4783

Question 5 A(v) the risk‐mitigating measures and, where relevant, surveillance of the disease are effective and proportionate to the risks posed by the disease in the Union

Answer Y ☐ N ☐ na ☐

Article 7 criteria Article 7 parameters Assessment of the Article 7 parameters from fact sheet
(a)(viii) Existence of diagnostic and disease control tools (a)(viii) 1 Existence of diagnostic tools <Information from the fact sheet>
(a)(viii) 2 Existence of disease control tools <Information from the fact sheet>
(b)(ii) Impact of the disease on human health (b)(ii) 7 Availability of medical treatment and their effectiveness (therapeutic effect and any resistance) <Information from the fact sheet>
(b)(ii) 8 Availability of vaccines and their effectiveness (reduced morbidity)
(d)(i) Feasibility, availability and effectiveness of diagnostic tools and capacities (d)(i) 1 officially/internationally recognised diagnostic tool, OIE certified <Information from the fact sheet>
(d)(i) 2 Se and Sp of diagnostic test <Information from the fact sheet>
(d)(i) 3 type of sample matrix to be tested (blood, tissue, etc.) <Information from the fact sheet>
(d)(ii) Feasibility, availability and effectiveness of vaccination (d)(ii) 1 types of vaccines available on the market <Information from the fact sheet>
(d)(ii) 2 availability/production capacity (per year) <Information from the fact sheet>
(d)(ii) 3 Field protection as reduced morbidity (reduced susceptibility to infection and/or to disease) <Information from the fact sheet>
(d)(ii) 4 Duration of protection <Information from the fact sheet>
(d)(ii) 5 Way of administration <Information from the fact sheet>
(d)(iii) Feasibility, availability and effectiveness of medical treatments (d)(iii) 1 types of drugs available on the market and/or allowed by the EU regulatory system <Information from the fact sheet>
(d)(iii) 2 availability/production capacity (per year) <Information from the fact sheet>
(d)(iii) 3 therapeutic effect in the field (effectiveness)
(d)(iii) 4 Way of administration
(d)(iv) Feasibility, availability and effectiveness of biosecurity measures (d)(iv) 1 available biosecurity measures <Information from the fact sheet>
(d)(iv) 2 effectiveness of biosecurity measure (description) <Information from the fact sheet>
(d)(iv) 3 feasibility of biosecurity measure (description) <Information from the fact sheet>
(d)(v) Feasibility, availability and effectiveness of restrictions on the movement of animals and products, as control measure (d)(v) 1 available restriction movement measures <Information from the fact sheet>
(d)(v) 2 effectiveness of restriction of animal movement in preventing the between farm spread (description) <Information from the fact sheet>
(d)(v) 3 feasibility of restriction of animal movement (description) <Information from the fact sheet>
(d)(vi) Feasibility, availability and effectiveness of killing of animals (d)(vi) 1 available killing of animal measures <Information from the fact sheet>
(d)(vi) 2 effectiveness of killing animals (at farm level or within the farm) for reducing/stopping spread of the disease (description) <Information from the fact sheet>
(d)(vi) 3 feasibility of killing animals (description) <Information from the fact sheet>
(d)(vii) feasibility, availability and Effectiveness of disposal of carcasses and other relevant animal by‐products (d)(vii) 1 disposal options available <Information from the fact sheet>
(d)(vii) 2 effectiveness of disposal option (description) <Information from the fact sheet>
(d)(vii) 3 feasibility of disposal option (description) <Information from the fact sheet>